LENZ Therapeutics, Inc.
LENZ
$4.73
$0.132.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -140.47% | -128.31% | -65.02% | 3.17% | 24.58% |
| Total Depreciation and Amortization | 403.33% | 306.74% | 394.83% | 454.05% | 190.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 394.79% | 552.34% | 344.00% | 65.08% | 37.18% |
| Change in Net Operating Assets | -245.14% | 271.67% | 129.41% | 164.17% | 132.51% |
| Cash from Operations | -141.25% | -68.35% | -16.47% | 36.56% | 36.01% |
| Capital Expenditure | 25.40% | -27.16% | -76.71% | -194.04% | -415.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.64% | 60.36% | 51.41% | 102.53% | 33.82% |
| Cash from Investing | 58.23% | 60.03% | 51.02% | 101.79% | 33.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 119.13% | 400.25% | 78.90% | -67.50% | 4.83% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -100.00% | -100.01% |
| Cash from Financing | 119.18% | 438.97% | -24.75% | -86.20% | -66.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.89% | 100.91% | 133.00% | -833.71% | -577.06% |